In this issue of Endocrinology and Metabolism Clinics of North America, guest editors Drs. Connie B. Newman and Alan Chait bring their considerable expertise to the topic of Lipids: Update on Diagnosis and Management of Dyslipidemia. When untreated, dyslipidemia may have serious comorbidities; in this issue, top experts cover the evaluation and management of LDL cholesterol and high triglicerides in adults and children, providing practical information that will help physicians and other health care professionals treat their patients and improve outcomes.
Contains 13 practice-oriented topics including lipid and lipoprotein metabolism; measurement of lipids and advanced lipid testing; assessment of CVD risk; inherited forms of hypercholesterolemia; new and emerging therapies for dyslipidemia; and more.
Provides in-depth clinical reviews on diagnosis and management of dyslipidemia, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Foreword - p. xiii 8. Preface - p. xv 9. Lipid and Lipoprotein Metabolism - p. 437 10. Lipoprotein Assessment in the twenty-first Century - p. 459 11. Assessment of Cardiovascular Disease Risk: A 2022 Update - p. 483 12. The Inherited Hypercholesterolemias - p. 511 13. Hypertriglyceridemia - p. 539 14. High-Density Lipoprotein and Cardiovascular Disease—Where do We Stand? - p. 557 15. Evaluation and Management of Lipids and Lipoproteins in Children and Adolescents - p. 573 16. Management of Dyslipidemia in Endocrine Diseases - p. 589 17. Dyslipidemia in Diabetes: When and How to Treat? - p. 603 18. Big Fish or No Fish; Eicosapentaenoic Acid and Cardiovascular Disease - p. 625 19. New and Emerging Therapies for Dyslipidemia - p. 635 20. Safety of Statins and Nonstatins for Treatment of Dyslipidemia - p. 655 21. LDL Cholesterol—How Low Can We Go? - p. 681
In this issue of Endocrinology and Metabolism Clinics of North America, guest editors Drs. Connie B. Newman and Alan Chait bring their considerable expertise to the topic of Lipids: Update on Diagnosis and Management of Dyslipidemia. When untreated, dyslipidemia may have serious comorbidities; in this issue, top experts cover the evaluation and management of LDL cholesterol and high triglicerides in adults and children, providing practical information that will help physicians and other health care professionals treat their patients and improve outcomes.
Contains 13 practice-oriented topics including lipid and lipoprotein metabolism; measurement of lipids and advanced lipid testing; assessment of CVD risk; inherited forms of hypercholesterolemia; new and emerging therapies for dyslipidemia; and more.
Provides in-depth clinical reviews on diagnosis and management of dyslipidemia, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Foreword - p. xiii 8. Preface - p. xv 9. Lipid and Lipoprotein Metabolism - p. 437 10. Lipoprotein Assessment in the twenty-first Century - p. 459 11. Assessment of Cardiovascular Disease Risk: A 2022 Update - p. 483 12. The Inherited Hypercholesterolemias - p. 511 13. Hypertriglyceridemia - p. 539 14. High-Density Lipoprotein and Cardiovascular Disease—Where do We Stand? - p. 557 15. Evaluation and Management of Lipids and Lipoproteins in Children and Adolescents - p. 573 16. Management of Dyslipidemia in Endocrine Diseases - p. 589 17. Dyslipidemia in Diabetes: When and How to Treat? - p. 603 18. Big Fish or No Fish; Eicosapentaenoic Acid and Cardiovascular Disease - p. 625 19. New and Emerging Therapies for Dyslipidemia - p. 635 20. Safety of Statins and Nonstatins for Treatment of Dyslipidemia - p. 655 21. LDL Cholesterol—How Low Can We Go? - p. 681
